Clinical trial

Xoft® Intraoperative Radiotherapy (IORT) for Patients With Early-Stage Breast Cancer

NCT04088435

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

RADIATION · Unmapped registry intervention Intraoperative radiotherapy Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Xoft® Intraoperative Radiotherapy (IORT) for Patients With Early-Stage Breast Cancer

Design: OBSERVATIONAL · Status: TERMINATED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusTERMINATED

Study typeOBSERVATIONAL

Start date2019-09-10

PhaseN/A

Conditions

Breast Cancerverified · MONDO: breast cancer

Breast Cancer, Invasive Ductalunresolved

Invasive Mammary Carcinomaverified · MONDO: invasive breast carcinoma

Breast Cancer Stage Iunresolved

Breast Cancer Stage IIAunresolved

Interventions

Intraoperative radiotherapyRADIATION

Sponsors & collaborators

University of Louisvillelead sponsor

Mapped research locations

LouisvilleKentucky, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04088435 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.